⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
Care Within Reach: How the Bristol Myers Squibb Foundation Is Strengthening Health Systems Across Africa
accessnewswire.com
BMY
Global Aptamer-Drug Conjugates Market Outlook, 2026-2032 - AI-Enabled Discovery and Precision Delivery Drive Growth Toward USD 2.14 Billion at a 15.79% CAGR
globenewswire.com
ABBV
ADCT
AZN
BMY
GSK
MRK
PFE
ROG
TAK
ZYME
Bristol Myers Squibb Announces First Presentation of Results for ZENBEXUS ™ (iberdomide) in Combination with Daratumumab from Phase 3 EXCALIBER-RRMM Trial in Relapsed or Refractory Multiple Myeloma
businesswire.com
BMY
Global Nanomedicine Market to Reach USD 581.2 Bn. by 2034, Driven by Rising Chronic Disease Prevalence, Expanding Nanotechnology-Based Drug Delivery, and Advances in Precision Diagnostics and Therapeutics Says Maximize Market Research
prnewswire.com
BMY
TEVA
SNY
Global Autoimmune Treatment Market to Reach USD 321.95 Billion by 2034, Driven by Rising Prevalence of Autoimmune Diseases, Growing Adoption of Biologics, and Advances in Precision Medicine Says Maximize Market Research
prnewswire.com
ABBV
JNJ
AMGN
BMY
PFE
NVS
SNY
LLY
AZN
UCB
BIIB
VTRS
GILD
KYMR
Global Multiple Sclerosis Treatment Market to Grow at 5.8% CAGR, Reaching USD 44.45 Billion by 2034 as Advanced Therapies and Disease-Modifying Treatments Gain Momentum, Says Maximize Market Research
prnewswire.com
NVS
BIIB
SNY
MRK
BMY
JNJ
TEVA
VTRS
AMGN
Global Autoimmune Disease Therapeutics Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight
globenewswire.com
ABBV
ABCL
AZN
BIIB
BMY
EXEL
GILD
GSK
INCY
LRCX
MRK
NVS
PFE
REGN
SNY
TMO
UCB
VRTX
Oncology Clinical Trials Market Set for Strong Growth Through 2035, Fueled by Precision Medicine, Immunotherapy and Decentralized Trial Innovation
globenewswire.com
AZN
MRK
NVS
LRCX
NVDA
GOOG
MSFT
AMGN
BMY
JNJ
PFE
LLY
ABBV
IQV
ICLR
LH
TMO
Global Bladder Cancer Treatment Market to Reach USD 11.33 Billion by 2034, Driven by Rising Disease Burden, Growing Adoption of Immunotherapy, and Advances in Targeted Cancer Therapies Reports Maximize Market Research
prnewswire.com
MRK
PFE
BMY
JNJ
AZN
CGON
ASRT
Global Protein Expression Market to Reach USD 7.30 Billion by 2034 at 8.8% CAGR as Rising Biopharmaceutical Development, Growing Demand for Recombinant Proteins, and Advances in Cell-Free Expression Technologies Accelerate Market Growth, Reports Maximize
prnewswire.com
TMO
AMGN
AGNC
BIO
QGEN
BIIB
GILD
REGN
BMY
MRK
SNY
LLY
ABBV
PFE
JNJ
AZN
BSX
MDLZ
GEHC
SYK
EW
ISRG
GOOG
MSFT
NVDA
AMAT
KLAC
LRCX
INTC
AMD
MU
WDC
SE
CRM
IBM
ORCL
SAP
ACN
GEN
PRG
EXAS
DXCM
ALGN
IDXX
VRTX
XRAY
CTAS
MDT
AMZN
GOOGL
CTSH
INFY
HPE
DELL
HPQ
LOGI
ADBE
CDNS
SNPS
MRVL
QCOM
NXPI
ON
ADI
TXN
MCHP
QRVO
NTAP
STX
WD
CRWD
PANW
FTNT
DDOG
SNOW
ETSY
ROKU
PYPL
MELI
JD
BABA
NTES
PDD
IQ
VIPS
NIO
LI
XPEV
RIVN
TSLA
GM
F
STLA
TM
VWAGY
HOG